VREX vareximaging.com: Multiplikator Forward P/S

Logo grafis Varex (VREX)

The forward EV/Revenue ratio demonstrates the asset's valuation dynamics, with the value fixed at 0.40. Varex Imaging (VREX) supplies X-ray components for security and medical systems, dominating the tubes and detectors segment. Revenues depend on equipment upgrade cycles, which creates moderate volatility. Results rely on CT scanner orders, requiring strict inventory control to maintain margins.

vareximaging.com - Rasio kapitalisasi marang dodolan sing dikarepake VREX (periode 04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan Varex Imaging Corp. (VREX)

- data kapitalisasi saham perusahaan:
Ringkesan analitik perusahaan:Varex Imaging Corporation (VREX)
Sampel barang Varex Imaging

To assess the long-term risks of Varex Imaging (VREX), it is essential to monitor market expectations regarding business capitalization. This indicator is calculated by dividing the company's current value by its projected revenue, reflecting the valuation's sensitivity to inflationary shocks. By analyzing the expected price-to-sales ratio, an investor can determine the speed at which the market revises the multiple. The technological indispensability of Varex Imaging (VREX) components in medical devices curbs the volatility of this metric, protecting share prices from dumping.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GE Healthcare Corp - Multiplikator Forward P/S|MTD (Mettler Toledo Inc) - Kapitalisasi marang prakiraan pendapatan|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Azenta Inc (AZTA)|Multiplikator Forward P/S SMLR|Multiplikator Forward P/S Butterfly Corp (BFLY)|Rasio rega marang prakiraan pendapatan Mesa Laboratories, Inc. MLAB|quantum-si.com - Rasio rega marang prakiraan pendapatan|NNOX: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QTRX (Quanterix Corp.)|MASS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CapsoVision (CV)|Rasio rega marang prakiraan pendapatan MaxCyte, Inc.|RPID - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SEER (Seer)|Multiplikator Forward P/S Hyperfine Inc (HYPR)|Multiplikator Forward P/S FONR (FONAR Corp)|Rasio kapitalisasi marang dodolan sing dikarepake Daxor Corp (DXR)|MDAI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan VIVS|Aclarion, Inc. (ACON) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Talis Biomedical Corp TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)